Acta Med. 2016, 59: 50-53
https://doi.org/10.14712/18059694.2016.89
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
Crossref Cited-by Linking
- Harrison Claire N., Kiladjian Jean‐Jacques, Koschmieder Steffen, Passamonti Francesco: Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives. Cancer 2024. <https://doi.org/10.1002/cncr.35244>
- Li Yujin, Zhu Shirong, Liu Weiyi, Ming Jing, Wang Xueying, Hu Xiaomei: Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to. Ann Hematol 2020, 99, 1161. <https://doi.org/10.1007/s00277-020-04028-z>
- Prednisone/thalidomide. Reactions Weekly 2017, 1644, 258. <https://doi.org/10.1007/s40278-017-28030-2>
